TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Genmab A/S
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period

Genmab has successfully acquired 94.2% of Merus N.V.'s outstanding shares at $97 per share, adding petosemtamab to its portfolio and positioning itself for potential billion-dollar revenue by 2029.

Insights
KMI   positive

Strong Q3 earnings (16% EPS growth), $9.3B project backlog, potential $10B additional projects, consistent dividend growth for 8 years, and expected earnings acceleration from 2027-2029


GMAB   positive

Completed strategic acquisition expanding pipeline, with potential for significant future revenue and growth in oncology